This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Board meeting scheduled on 26 Oct 2026 for Q2 FY27 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.8 pts more than Nifty Microcap 250 and 7.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syschem India has informed BSE that its Board of Directors will meet on 26 October 2026 at 11:00 AM to consider and approve the unaudited financial results for the quarter ended 30 September 2026 (Q2 FY27). Other business may be taken up with the chairperson's consent. As per the insider trading code, the trading window for designated persons and their immediate relatives will remain closed until 48 hours after the results are declared.
Investors should track the Q2 FY27 results announcement on or after 27 October 2026 for the earnings update.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹129.8 Cr | ₹117.9 Cr | +10.1% |
| Operating profit | ₹2.13 Cr | ₹2.54 Cr | −16.0% |
| Profit after tax | ₹1.91 Cr | ₹1.90 Cr | +0.7% |
| EBITDA margin | 3.4% | 2.8% | +0.6 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.